| 发明名称 |
Pulmonary administration of chemically modified insulin |
| 摘要 |
The present invention provides active, hydrophilic polymer-modified derivatives of insulin. The insulin derivatives of the invention are, in one aspect, suitable for delivery to the lung and exhibit pharmakokinetic and/or pharmacodynamic properties that are significantly improved over native insulin.
|
| 申请公布号 |
US6838076(B2) |
申请公布日期 |
2005.01.04 |
| 申请号 |
US20020154057 |
申请日期 |
2002.05.21 |
| 申请人 |
NEKTAR THERAPEUTICS |
发明人 |
PATTON JOHN S.;KUO MEI-CHANG;HARRIS J. MILTON;LEACH CHESTER;PERKINS KIMBERLY;BUECHE BLAINE |
| 分类号 |
A61K9/08;A61K9/12;A61K9/19;A61K9/24;A61K9/72;A61K38/00;A61K38/16;A61K38/28;A61K47/34;A61K47/48;A61L9/04;A61P3/10;C07K14/62;(IPC1-7):A61K38/00 |
主分类号 |
A61K9/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
